LONG-TERM EFFECTS OF CELL THERAPY ON ENDOTHELIAL DYSFUNCTION DURING MONOCROTALINE PULMONARY HYPERTENSION

The article presents data on the levels of key markers of endothelial dysfunction — metabolites of nitric oxide, endothelin-1, von Willebrand factor — in rats with monocrotaline pulmonary hypertension in different periods after use of mesenchymal stem cells.